Updated June 2025

GLP-1 Drugs
in India.

A complete, honest guide to availability, pricing, and CDSCO approval status for every major GLP-1 medication in India — updated monthly.

Medical Disclaimer: GLP-1 medications require a valid prescription from a licensed physician in India. Do not self-medicate. Prices listed are estimates and vary by city, pharmacy, and availability.

01
CDSCO Approved

Generic Semaglutide (Injectable)

Semaglutide · Dr. Reddy's, Sun Pharma, Zydus, Glenmark, Alkem · Weekly injection (pen/vial)

₹1,300 – ₹4,200 / month

estimated monthly cost

Key Info

Avg. Weight Loss

~14-15%

Frequency

Once weekly

India Indication

Type 2 Diabetes & Chronic Weight Management

Availability

Widely available across India through major pharmacies and hospitals

Available Doses

0.25mg0.5mg1mg

Pros

Most affordable GLP-1 option in India
Up to 80% cheaper than branded semaglutide
Multiple manufacturers improve availability

Cons

Brand quality may vary
Some products still use vial format
Higher doses may be harder to source
Our Take

The best value-for-money GLP-1 therapy currently available in India.

02
CDSCO Approved

Rybelsus

Oral Semaglutide · Novo Nordisk · Tablet (oral)

₹3,500 – ₹8,500 / month

estimated monthly cost

Key Info

Avg. Weight Loss

~8-10%

Frequency

Once daily

India Indication

Type 2 Diabetes

Availability

Widely available nationwide

Available Doses

3mg7mg14mg

Pros

Only oral GLP-1 available in India
No injections required
Well-established safety profile

Cons

Less weight loss than injectable options
Requires fasting administration
Patent protection keeps pricing relatively high
Our Take

The leading oral GLP-1 option for patients who prefer tablets over injections.

03
CDSCO Approved

Wegovy

Semaglutide 2.4mg · Novo Nordisk · Weekly injection pen

₹5,660 – ₹16,400 / month

estimated monthly cost

Key Info

Avg. Weight Loss

~15-17%

Frequency

Once weekly

India Indication

Obesity & Chronic Weight Management

Availability

Available through major hospitals, obesity clinics and retail pharmacy chains

Available Doses

0.25mg0.5mg1mg1.7mg2.4mg

Pros

Gold-standard semaglutide weight-loss therapy
Official obesity indication
Significantly cheaper after 2026 price cuts

Cons

Still more expensive than Indian generics
Long-term treatment remains costly
Premium brand pricing persists at higher doses
Our Take

The premium branded semaglutide option, now considerably more affordable than at launch.

04
CDSCO Approved

Mounjaro

Tirzepatide · Eli Lilly · Weekly injection pen

₹14,000 – ₹27,500 / month

estimated monthly cost

Key Info

Avg. Weight Loss

~21-22%

Frequency

Once weekly

India Indication

Type 2 Diabetes & Weight Management

Availability

Available nationwide through Lilly distribution partners and major pharmacy networks

Available Doses

2.5mg5mg7.5mg10mg12.5mg15mg

Pros

Highest weight-loss efficacy available in India
Dual GIP + GLP-1 mechanism
Full dose escalation pathway available

Cons

Most expensive obesity treatment in India
Requires refrigeration
Insurance coverage remains limited
Our Take

The most effective weight-loss medication currently available in India, provided budget is not the primary concern.

05
CDSCO Approved

Ozempic

Semaglutide · Novo Nordisk · Weekly injection pen

₹8,800 – ₹11,200 / month

estimated monthly cost

Key Info

Avg. Weight Loss

~10-14%

Frequency

Once weekly

India Indication

Type 2 Diabetes

Availability

Available through major pharmacy chains and diabetes clinics

Available Doses

0.25mg0.5mg1mg

Pros

Trusted global semaglutide brand
Easy-to-use pen device
Strong diabetes control benefits

Cons

More expensive than generic semaglutide
Not specifically approved for obesity
Limited maximum dose compared with Wegovy
Our Take

An excellent diabetes-focused semaglutide option, though most weight-loss patients will find better value in Wegovy or generics.

Pricing changes monthly.We track it for you.

Subscribe for monthly price updates, new approvals, and access guides.

No spam. Unsubscribe anytime. India-focused content only.